Location: 900 Boylston Street Boston, Massachusetts
Date: June 4th-6th, 2017
Email: [email protected]
General Admission: $500 Early Bird, $550 On-site
Booth Pricing: Contact for more information
About: On behalf of the conference chairman Prof. Raphael Mechoulam, it is with great pleasure that we invite you to join us at the Cann10 2nd International Medical Cannabis Conference, to be held on June 4-6, 2017, in Tel Aviv, Israel.
It has been less than a year since the first successful Cann10 Conference, where 80 speakers from around the world shared their knowledge with more than 600 participants from over 30 countries. Extensive media coverage was received via leading outlets such as Bloomberg, Forbes, The Jerusalem Post, i24news.TV, Globes, Calcalist, Ynet.
A great deal has happened in Israel and globally in these past few months. Among the events, medical cannabis has been approved in even more states in the US, bringing the total number to 28. Meanwhile, scores of other countries are endorsing cannabis as evidence-based medical treatment, and are allocating necessary resources for research, technology, and health care.
Israel is proud to be at the forefront of research, innovation, and new technologies in the medical cannabis space, and has created a dynamic ecosystem that has served to expand the “Startup Nation” experience to new frontiers.
Cann10 Conference 2017 is the international gateway for knowledge-sharing in this evolving field. Professionals from different sectors will attend, joining us to learn about the latest developments in medical cannabis and its benefits.
The conference will explore three main themes: Medical/Scientific, Agriculture/Genetics, and Technology/Commerce/Innovation. It will be an outstanding opportunity to meet with global experts in the medical cannabis field, as well as an important platform for sharing research, business opportunities, and cooperative educational efforts.
We look forward to welcoming you to what promises to be an exciting and rewarding meeting of the highest scientific standards.
Yossi Bornstein, CEO